Finch Trades

As of market close
November 20, 2026
Update frequency: every Saturday morning
Click individual row to view transaction details
For transparency, I also own equity in the following private companies: Genetic Assemblies (autonomous oligo manufacturing), Skyhawk Therapeutics (neuro drug developer)

$53,153

Principal

$105,277

Current Value

98.1%

Total Return
(from April 2024)

30.5%

CAGR
(from April 2024)
Finch Trades
$FINCH
$53,153
$105,277
$52,124
98.1%
0.0%
If S&P 500
$SPY
$53,153
$69,799
$16,646
31.3%
66.7%
If XBI
$XBI
$53,153
$83,105
$29,952
56.4%
41.7%
If Nasdaq 100
$QQQ
$53,153
$67,097
$13,944
26.2%
71.8%
If ARKG
$ARKG
$53,153
$81,405
$28,252
53.2%
44.9%
Opportunistic
$22,750
$25,012
9.9%
11.3%
12.5%
14.1%
13.9%
Future Compounder
$46,421
$95,645
106.0%
87.8%
83.9%
63.3%
55.6%
Current Compounder
$24,245
$24,417
0.7%
-20.2%
-23.6%
-50.8%
-30.6%
* This view tracks performance by the portfolio allocation group without accounting for reinvested proceeds.
2024
$23,721
$53,902
127.2%
96.7%
87.9%
68.0%
65.4%
2025
$52,495
$73,306
39.6%
26.0%
24.7%
7.4%
16.5%
2026
$17,200
$18,332
6.6%
7.4%
10.1%
-1.5%
-17.7%
* This view tracks performance by the year principal was invested without accounting for reinvested proceeds.